| Update on ethambutol optic neuropathy. | |
MedLine Citation:
|
PMID: 16907651 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Ethambutol optic neuropathy is a well-recognised adverse ocular event in patients who receive ethambutol for the treatment of mycobacterial infections. Much has been published on this condition; however, understanding of patient outcomes and the mechanism by which ethambutol optic neuropathy occurs, as well as data published in textbooks and reference books, tend to lag behind what is currently known. The purpose of this article is to update the clinician on what is currently accepted in regards to the clinical presentation of ethambutol optic neuropathy and what type of eye care should be provided to patients treated with this medication. In addition, new treatment recommendations are suggested to assist clinicians in complying with currently accepted standards of care. |
Authors:
|
Frederick W Fraunfelder; Alfredo A Sadun; Terry Wood |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Expert opinion on drug safety Volume: 5 ISSN: 1744-764X ISO Abbreviation: Expert Opin Drug Saf Publication Date: 2006 Sep |
Date Detail:
|
Created Date: 2006-08-15 Completed Date: 2006-08-23 Revised Date: 2008-04-14 |
Medline Journal Info:
|
Nlm Unique ID: 101163027 Medline TA: Expert Opin Drug Saf Country: England |
Other Details:
|
Languages: eng Pagination: 615-8 Citation Subset: IM |
Affiliation:
|
Casey Eye Institute, Oregon Health & Science University, 3375 S.W. Terwilliger Boulevard, Portland, OR 97239-4197, USA. fraunfer@ohsu.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antitubercular Agents
/
adverse effects*,
metabolism Ethambutol / adverse effects*, metabolism Humans Optic Nerve Diseases / chemically induced*, physiopathology Product Surveillance, Postmarketing |
| Chemical | |
Reg. No./Substance:
|
0/Antitubercular Agents; 74-55-5/Ethambutol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The withdrawal of antiepileptic drugs in patients with non-epileptic seizures: safety considerations...
Next Document: Cardiac dysfunction associated with trastuzumab.